BriaCell Therapeutics Corp. - *W EXP 02/24/202 (BCTXW)

Historical Institutional Holders from Q1 2021 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Equity / *W EXP 02/24/202
Shares, excl. options Q4 2024
457K
Holdings value Q4 2024
$129K
Value change Q4 2024
-$6.54K
Grand Portfolio weight change Q4 2024
0%
Number of holders
4
Number of buys Q4 2024
0
Number of sells Q4 2024
-1
Average buys Q4 2024 %
0
Average sells Q4 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 457K $129K -$6.54K $0.29 4
2024 Q3 480K $197K +$7.8K $0.41 4
2024 Q2 461K $121K +$2.7K $0.25 4
2024 Q1 451K $609K +$1.04K $1.30 3
2023 Q4 450K $1.13M -$112K $2.50 2
2023 Q3 495K $1.22M -$330K $2.47 4
2023 Q2 629K $1.57M -$281K $2.50 5
2023 Q1 743K $2.19M -$1.77M $2.96 4
2022 Q4 1.55M $3.29M +$77.9K $2.06 8
2022 Q3 1.51M $4.26M +$289K $2.87 7
2022 Q2 1.4M $3.64M +$552K $2.60 7
2022 Q1 1.17M $6.11M +$894K $5.20 9
2021 Q4 1M $4.64M +$430K $4.69 5
2021 Q3 906K $4.31M +$844K $4.77 8
2021 Q2 878K $1.58M -$591K $1.80 10
2021 Q1 1.11M $1.19M +$1.19M $1.07 6